By Dr Sandeep Sancheti The next generation of youth needs to be engaged with the contemporary…
Tag: GIVE
India’s First Home-Grown Cervical Cancer Vaccine To Be Available In The Market This Month
The Serum Institute of India’s (SII) quadrivalent human papillomavirus (qHPV) vaccine ‘CERVAVAC’ will be available in…
DCGI Approves Market Authorisation for SII’s Covid Vaccine Covovax as Heterologous Booster Dose
Last Updated: January 17, 2023, 00:00 IST Covovax is manufactured through technology transfer from Novavax. (Image:…
Covid: Serum Institute To Provide 2 Crore Covishield Doses To Govt Free Of Cost, Says Report
New Delhi: The Serum Institute of India (SII) has provided the central government with two crore…
Serum Institute Seeks Drug Regulator’s Approval Of Covovax As Covid Booster Dose: Report
New Delhi: The Serum Institute of India (SII) sought the Drugs Controller General of India (DCGI)…
People fed up of Covid-19 pandemic, no takers for booster jabs: SII CEO Adar Poonawalla
New Delhi: Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday (October…
SII stopped Covishield production last year; says Adar Poonawalla; claims nearly 100 million doses expired
Image Source : PTI/REPRESENTATIVE No takers for booster doses, SII stops Covishield production Highlights Adar Poonawalla…
People Fed Up Of Covid & Vaccines, SII Not Making Covishield Since Dec 2021: Adar Poonawalla
New Delhi: Chief Executive Officer of Serum Institute of India (SII) Adar Poonawalla said that the…
Explained: As India Unveils SII’s CERVAVAC, Know How Cervical Cancer Vaccines Work
Pune-based pharmaceutical firm Serum Institute of India (SII) will soon launch CERVAVAC, India’s first indigenously developed…